Biosimilars Market In-depth Research covering sales outlook, demand forecast & up-to-date key trends
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The global Biosimilars market is expected to grow at a CAGR of 18.7% during the forecast period.
The global Biosimilars market is estimated to be about 5872.3 million US dollars in 2020.
The global Biosimilars market is estimated to reach 11644.2 million USD by 2026.
The global Biosimilars market is segmented by company, region (country), type and application. Participants, stakeholders, and other readers in the global Biosimilars market will be able to gain an advantage as they use reports as a powerful resource.
Biosimilars markets by category
Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
Recombinant Glycosylated Proteins
Biosimilars Market by Application (Percentage of Demand)
Oncology
Blood Disorders
Growth Hormonal Deficiency
Chronic and Autoimmune Disorders
Others
Who are the leading companies in Biosimilars
Pfizer
Novartis
Biocon
Biogen
Fresenius Kabi AG
Boehringer Ingelheim
Merck KgaA
Mylan
Eli Lilly
Teva Pharmaceutical
Dr. Reddy's Laboratories
Amgen
Celltrion
Samsung Biologics
Roche
Probiomed
Apotex
Chong Kun Dang
JCR Pharmaceuticals
Gan & Lee Pharmaceuticals
Gedeon Richter
Biocad
Coherus Bioscience
Stada Arzneimittel AG
Biosimilars markets by region:
In North America
In Latin America
Europe
The Asia-pacific
Middle East and Africa (MEA)
What are the main countries covered
The United States
Canada
Germany
France
UK
Italy
Russia
China
Japan
Korea
Southeast Asia
India
Australia
Brazil
Mexico
Argentina
Chile
Colombia
Egypt
Saudi Arabia
United Arab Emirates
Nigeria
South Africa
Which is the most profitable market
Among regions, North America/Europe/Asia Pacific accounted for the largest share of global personalized beauty equipment as rising consumer incomes led to increased spending at Biosimilars.
What methodology did you follow in your research
This study was conducted by our expert analysts through a combination of primary and secondary studies. The methodology we follow includes a demand-side assessment of the market and triangulation of this through supply-side analysis. The methodology is based on the use of standard market structures, methods, and definitions.
Who were the primary study respondents
We talk to stakeholders across the spectrum. Including C-level executives, distributors, product manufacturers, industry experts, etc.
What are the sources of secondary research
We conduct extensive secondary studies using proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations and research papers.
1. Introduction
1.1 Definition of the Market
1.2 Research Purpose
1.3 Scope of the Study
1.4 Stakeholders
1.5 Geography Coverage
1.6 Currency Under Consideration
1.7 Market Size Units
1.8 Review Cycle
2 Global Market Overview
2.1 Global Biosimilars Revenue and Growth Forecast 2014-2026
2.2 Global Biosimilars Market Size and Growth Forecast 2014-2026
2.3 Global Biosimilars Revenue by Region 2014-2026
2.4 Biosimilars Market Share by Major Regions 2014-2021
2.5 Biosimilars Gross Margin in Different Region 2014-2021
2.6 Global Biosimilars Market History Price and Forecast 2014-2026
2.7 Global Biosimilars Sales Market Share by Top Companies 2014-2021
3 Global Biosimilars Market by Type
3.1 Global Biosimilars Revenue and Growth Rate Segment by Types from 2014-2021
3.2 Global Biosimilars Market Size and Growth Rate Segment by Product Types from 2014-2021
3.3 Global Biosimilars Price Segment by Types from 2014-2021
3.4 Brief Introduction of Different Types
3.4.1 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
3.4.2 Recombinant Glycosylated Proteins
4 Global Biosimilars Market by Application
4.1 Global Biosimilars Revenue and Growth Rate Segment by Applications from 2014-2021
4.2 Global Biosimilars Market Size and Growth Rate Segment by Product Applications from 2014-2021
4.3 Brief Introduction of Different Applications
4.3.1 Oncology
4.3.2 Blood Disorders
4.3.3 Growth Hormonal Deficiency
4.3.4 Chronic and Autoimmune Disorders
4.3.5 Others
5 North America Biosimilars Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
5.1 North America Biosimilars Value ($) from 2014-2021
5.2 North America Biosimilars Market Size from 2014-2021
5.3 North America Biosimilars Price Change from 2014-2021
5.4 North America Biosimilars Import and Export from 2014-2021
5.5 North America Biosimilars Market Value ($) and Growth (%) by Type from 2014-2021
5.6 North America Biosimilars Market Value ($) and Growth (%) by Application from 2014-2021
5.7 North America Biosimilars Market Value ($) and Growth (%) by Countries from 2014-2021
5.7.1 The United States
5.7.2 Canada
5.8 Top North America Biosimilars Participants Value ($) and Market Share (%) in 2020
6 Europe Biosimilars Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
6.1 Europe Biosimilars Value ($) from 2014-2021
6.2 Europe Biosimilars Market Size from 2014-2021
6.3 Europe Biosimilars Price Change from 2014-2021
6.4 Europe Biosimilars Import and Export from 2014-2021
6.5 Europe Biosimilars Market Value ($) and Growth (%) by Type from 2014-2021
6.6 Europe Biosimilars Market Value ($) and Growth (%) by Application from 2014-2021
6.7 Europe Biosimilars Market Value ($) and Growth (%) by Countries from 2014-2021
6.7.1 Germany
6.7.2 France
6.7.3 UK
6.7.4 Italy
6.7.5 Russia
…
6.8 Top Europe Biosimilars Participants Value ($) and Market Share (%) in 2020
7 Asia-Pacific Biosimilars Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
7.1 Asia-Pacific Biosimilars Value ($) from 2014-2021
7.2 Asia-Pacific Biosimilars Market Size from 2014-2021
7.3 Asia-Pacific Biosimilars Price Change from 2014-2021
7.4 Asia-Pacific Biosimilars Import and Export from 2014-2021
7.5 Asia-Pacific Biosimilars Market Value ($) and Growth (%) by Type from 2014-2021
7.6 Asia-Pacific Biosimilars Market Value ($) and Growth (%) by Application from 2014-2021
7.7 Asia-Pacific Biosimilars Market Value ($) and Growth (%) by Countries from 2014-2021
7.7.1 China
7.7.2 Japan
7.7.3 Korea
7.7.4 Southeast Asia
7.7.5 India
7.7.6 Australia
…
7.8 Top Asia-Pacific Biosimilars Participants Value ($) and Market Share (%) in 2020
8 Latin America Biosimilars Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
8.1 Latin America Biosimilars Value ($) from 2014-2021
8.2 Latin America Biosimilars Market Size from 2014-2021
8.3 Latin America Biosimilars Price Change from 2014-2021
8.4 Latin America Biosimilars Import and Export from 2014-2021
8.5 Latin America Biosimilars Market Value ($) and Growth (%) by Type from 2014-2021
8.6 Latin America Biosimilars Market Value ($) and Growth (%) by Application from 2014-2021
8.7 Latin America Biosimilars Market Value ($) and Growth (%) by Countries from 2014-2021
8.7.1 Brazil
8.7.2 Mexico
8.7.3 Argentina
8.7.4 Chile
8.7.5 Colombia
…
8.8 Top Latin America Biosimilars Participants Value ($) and Market Share (%) in 2020
9 Middle East & Africa Biosimilars Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
9.1 Middle East & Africa Biosimilars Value ($) from 2014-2021
9.2 Middle East & Africa Biosimilars Market Size from 2014-2021
9.3 Middle East & Africa Biosimilars Price Change from 2014-2021
9.4 Middle East & Africa Biosimilars Import and Export from 2014-2021
9.5 Middle East & Africa Biosimilars Market Value ($) and Growth (%) by Type from 2014-2021
9.6 Middle East & Africa Biosimilars Market Value ($) and Growth (%) by Application from 2014-2021
9.7 Middle East & Africa Biosimilars Market Value ($) and Growth (%) by Countries from 2014-2021
9.7.1 Egypt
9.7.2 Saudi Arabia
9.7.3 United Arab Emirates
9.7.4 Nigeria
9.7.5 South Africa
…
9.8 Top Middle East & Africa Biosimilars Participants Value ($) and Market Share (%) in 2020
10. Global Level Competitive Intelligence – Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.1.2 Pfizer Sales, Value, Gross and Gross Margin from 2014-2021
10.1.3 Pfizer Value and Growth Change from 2014-2021
10.1.4 Pfizer Price Change from 2014-2021
10.1.5 Pfizer Product Offered
10.2 Novartis
10.2.1 Novartis Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.2.2 Novartis Sales, Value, Gross and Gross Margin from 2014-2021
10.2.3 Novartis Value and Growth Change from 2014-2021
10.2.4 Novartis Price Change from 2014-2021
10.2.5 Novartis Product Offered
10.3 Biocon
10.3.1 Biocon Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.3.2 Biocon Sales, Value, Gross and Gross Margin from 2014-2021
10.3.3 Biocon Value and Growth Change from 2014-2021
10.3.4 Biocon Price Change from 2014-2021
10.3.5 Biocon Product Offered
10.4 Biogen
10.4.1 Biogen Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.4.2 Biogen Sales, Value, Gross and Gross Margin from 2014-2021
10.4.3 Biogen Value and Growth Change from 2014-2021
10.4.4 Biogen Price Change from 2014-2021
10.4.5 Biogen Product Offered
10.5 Fresenius Kabi AG
10.5.1 Fresenius Kabi AG Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.5.2 Fresenius Kabi AG Sales, Value, Gross and Gross Margin from 2014-2021
10.5.3 Fresenius Kabi AG Value and Growth Change from 2014-2021
10.5.4 Fresenius Kabi AG Price Change from 2014-2021
10.5.5 Fresenius Kabi AG Product Offered
10.6 Boehringer Ingelheim
10.6.1 Boehringer Ingelheim Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.6.2 Boehringer Ingelheim Sales, Value, Gross and Gross Margin from 2014-2021
10.6.3 Boehringer Ingelheim Value and Growth Change from 2014-2021
10.6.4 Boehringer Ingelheim Price Change from 2014-2021
10.6.5 Boehringer Ingelheim Product Offered
10.7 Merck KgaA
10.7.1 Merck KgaA Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.7.2 Merck KgaA Sales, Value, Gross and Gross Margin from 2014-2021
10.7.3 Merck KgaA Value and Growth Change from 2014-2021
10.7.4 Merck KgaA Price Change from 2014-2021
10.7.5 Merck KgaA Product Offered
10.8 Mylan
10.8.1 Mylan Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.8.2 Mylan Sales, Value, Gross and Gross Margin from 2014-2021
10.8.3 Mylan Value and Growth Change from 2014-2021
10.8.4 Mylan Price Change from 2014-2021
10.8.5 Mylan Product Offered
10.9 Eli Lilly
10.9.1 Eli Lilly Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.9.2 Eli Lilly Sales, Value, Gross and Gross Margin from 2014-2021
10.9.3 Eli Lilly Value and Growth Change from 2014-2021
10.9.4 Eli Lilly Price Change from 2014-2021
10.9.5 Eli Lilly Product Offered
10.10 Teva Pharmaceutical
10.10.1 Teva Pharmaceutical Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.10.2 Teva Pharmaceutical Sales, Value, Gross and Gross Margin from 2014-2021
10.10.3 Teva Pharmaceutical Value and Growth Change from 2014-2021
10.10.4 Teva Pharmaceutical Price Change from 2014-2021
10.10.5 Teva Pharmaceutical Product Offered
10.11 Dr. Reddy's Laboratories
10.11.1 Dr. Reddy's Laboratories Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.11.2 Dr. Reddy's Laboratories Sales, Value, Gross and Gross Margin from 2014-2021
10.11.3 Dr. Reddy's Laboratories Value and Growth Change from 2014-2021
10.11.4 Dr. Reddy's Laboratories Price Change from 2014-2021
10.11.5 Dr. Reddy's Laboratories Product Offered
10.12 Amgen
10.12.1 Amgen Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.12.2 Amgen Sales, Value, Gross and Gross Margin from 2014-2021
10.12.3 Amgen Value and Growth Change from 2014-2021
10.12.4 Amgen Price Change from 2014-2021
10.12.5 Amgen Product Offered
10.13 Celltrion
10.13.1 Celltrion Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.13.2 Celltrion Sales, Value, Gross and Gross Margin from 2014-2021
10.13.3 Celltrion Value and Growth Change from 2014-2021
10.13.4 Celltrion Price Change from 2014-2021
10.13.5 Celltrion Product Offered
10.14 Samsung Biologics
10.14.1 Samsung Biologics Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.14.2 Samsung Biologics Sales, Value, Gross and Gross Margin from 2014-2021
10.14.3 Samsung Biologics Value and Growth Change from 2014-2021
10.14.4 Samsung Biologics Price Change from 2014-2021
10.14.5 Samsung Biologics Product Offered
10.15 Roche
10.15.1 Roche Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.15.2 Roche Sales, Value, Gross and Gross Margin from 2014-2021
10.15.3 Roche Value and Growth Change from 2014-2021
10.15.4 Roche Price Change from 2014-2021
10.15.5 Roche Product Offered
10.16 Probiomed
10.16.1 Probiomed Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.16.2 Probiomed Sales, Value, Gross and Gross Margin from 2014-2021
10.16.3 Probiomed Value and Growth Change from 2014-2021
10.16.4 Probiomed Price Change from 2014-2021
10.16.5 Probiomed Product Offered
10.17 Apotex
10.17.1 Apotex Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.17.2 Apotex Sales, Value, Gross and Gross Margin from 2014-2021
10.17.3 Apotex Value and Growth Change from 2014-2021
10.17.4 Apotex Price Change from 2014-2021
10.17.5 Apotex Product Offered
10.18 Chong Kun Dang
10.18.1 Chong Kun Dang Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.18.2 Chong Kun Dang Sales, Value, Gross and Gross Margin from 2014-2021
10.18.3 Chong Kun Dang Value and Growth Change from 2014-2021
10.18.4 Chong Kun Dang Price Change from 2014-2021
10.18.5 Chong Kun Dang Product Offered
10.19 JCR Pharmaceuticals
10.19.1 JCR Pharmaceuticals Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.19.2 JCR Pharmaceuticals Sales, Value, Gross and Gross Margin from 2014-2021
10.19.3 JCR Pharmaceuticals Value and Growth Change from 2014-2021
10.19.4 JCR Pharmaceuticals Price Change from 2014-2021
10.19.5 JCR Pharmaceuticals Product Offered
10.20 Gan & Lee Pharmaceuticals
10.20.1 Gan & Lee Pharmaceuticals Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.20.2 Gan & Lee Pharmaceuticals Sales, Value, Gross and Gross Margin from 2014-2021
10.20.3 Gan & Lee Pharmaceuticals Value and Growth Change from 2014-2021
10.20.4 Gan & Lee Pharmaceuticals Price Change from 2014-2021
10.20.5 Gan & Lee Pharmaceuticals Product Offered
10.21 Gedeon Richter
10.21.1 Gedeon Richter Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.21.2 Gedeon Richter Sales, Value, Gross and Gross Margin from 2014-2021
10.21.3 Gedeon Richter Value and Growth Change from 2014-2021
10.21.4 Gedeon Richter Price Change from 2014-2021
10.21.5 Gedeon Richter Product Offered
10.22 Biocad
10.22.1 Biocad Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.22.2 Biocad Sales, Value, Gross and Gross Margin from 2014-2021
10.22.3 Biocad Value and Growth Change from 2014-2021
10.22.4 Biocad Price Change from 2014-2021
10.22.5 Biocad Product Offered
10.23 Coherus Bioscience
10.23.1 Coherus Bioscience Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.23.2 Coherus Bioscience Sales, Value, Gross and Gross Margin from 2014-2021
10.23.3 Coherus Bioscience Value and Growth Change from 2014-2021
10.23.4 Coherus Bioscience Price Change from 2014-2021
10.23.5 Coherus Bioscience Product Offered
10.24 Stada Arzneimittel AG
10.24.1 Stada Arzneimittel AG Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.24.2 Stada Arzneimittel AG Sales, Value, Gross and Gross Margin from 2014-2021
10.24.3 Stada Arzneimittel AG Value and Growth Change from 2014-2021
10.24.4 Stada Arzneimittel AG Price Change from 2014-2021
10.24.5 Stada Arzneimittel AG Product Offered
11. Market Dynamics
11.1 Driving Factors
11.1.1 Rising Demand in Some Regions: North America/Europe/China/India/Japan …
11.1.2 Increasing Use of Biosimilars by Different End-User/Applications
11.2 Restraints and Challenges in the Market
11.3 Opportunities
11.4 Covid-19 Impact/Evaluation
12. Future Forecast of Global Biosimilars Market from 2020-2026
12.1 Future Forecast of Global Biosimilars Market from 2020-2026 Segment by Regions
12.2 Future Forecast of Global Biosimilars Market from 2020-2026 Segment by Type
12.3 Future Forecast of Global Biosimilars Market from 2020-2026 Segment by Application
13. Investment Analysis
13.1 Fundamental Analysis (Porter's Five Forces Analysis)
13.2 Technical Preparation Analysis
13.3 Risk Evaluating Analysis
13.4 Estimated Investment Pay-Back Period
14 Research Methodology
14.1 Research Data
14.1.1 Secondary Data
14.1.2 Primary Data
14.2 Revenue Estimation
14.2.1 Bottom-Up Approach
14.2.2 Top-Down Approach (Involves time, Space, and Persons)
14.3 Data Triangulation
14.4 Assumptions
14.5 Hypothesis of this Research, Clear, specific, and testable statement of this research
14.6 Limitations of Our Study
14.7 Scene Based Modeling
15 Disclaimer
Research Methodology:
Biosimilars Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|